Literature DB >> 24949519

Copper and silver complexes of tris(triazole)amine and tris(benzimidazole)amine ligands: evidence that catalysis of an azide-alkyne cycloaddition ("click") reaction by a silver tris(triazole)amine complex arises from copper impurities.

Timothy U Connell1, Christine Schieber, Ilaria Proietti Silvestri, Jonathan M White, Spencer J Williams, Paul S Donnelly.   

Abstract

The synthesis and characterization of a silver complex of the tripodal triazole ligand, tris(benzyltriazolylmethyl)amine (TBTA, L(1)), that is used as promoter to enhance Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) reactions is reported. X-ray analysis of the silver(I) complex with L(1) reveals a dinuclear cation, [Ag2(L(1))2](2+), that is essentially isostructural to the copper(I) analogue. While the [Ag2(L(1))2](BF4)2 complex provides catalysis for the azide-alkyne cycloaddition process, evidence is presented that this arises from trace copper contamination. The synthesis of silver(I), copper(II), and copper(I) complexes of a second tripodal ligand, tris(2-benzimidazolymethyl)amine (L(2)), which is used to enhance the rate of CuAAC reactions, is also reported. X-ray crystallography of the Cu(I) complex [Cu(I)3(L(2))2(CH3CN)2](BF4)3 offers structural insight into previous mechanistic speculation about the role of this ligand in the CuAAC reaction.

Entities:  

Year:  2014        PMID: 24949519     DOI: 10.1021/ic5008999

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  2 in total

1.  Silver-catalysed azide-alkyne cycloaddition (AgAAC): assessing the mechanism by density functional theory calculations.

Authors:  Biswadip Banerji; K Chandrasekhar; Sunil Kumar Killi; Sumit Kumar Pramanik; Pal Uttam; Sudeshna Sen; Nakul Chandra Maiti
Journal:  R Soc Open Sci       Date:  2016-09-14       Impact factor: 2.963

2.  Design, Synthesis, and Characterization of Novel Coordination Compounds of Benzimidazole Derivatives with Cadmium.

Authors:  Anita Raducka; Marcin Świątkowski; Izabela Korona-Głowniak; Barbara Kaproń; Tomasz Plech; Małgorzata Szczesio; Katarzyna Gobis; Agnieszka Czylkowska
Journal:  Pharmaceutics       Date:  2022-08-03       Impact factor: 6.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.